Skip to content

Radiation Oncology Alternative Payment Model (RO-APM)—the Future of Value-Based Care

Accuray Enables the Future of Radiation Oncology Care Model

On September 18, 2020 the final announcement of the Alternative Payment Model for Radiation Oncology (RO-APM) from the Centers for Medicare & Medicaid Services (CMS) and the Center for Medicare and Medicaid Innovation (CMMI) affirmed the complexity of the rule. As expected, the model outlines a progressive course towards value-based care and bundled payments. At Accuray, we’ve been leading the way for nearly two decades. Our legacy of innovation has always centered on a fundamental truth of value-based radiation oncology.

Medicare Radiation Oncology Alternative Payment Model: what you need to know

View our new webinar discussing an overview of the Medicare Radiation Oncology Alternative Payment Model (RO-APM).

Thriving Under the Radiation Oncology Alternative Payment Model: A Definitive Guide to a New Reality

Get an in-depth look at how the RO-APM will reshape the future of radiation oncology. Learn how greater accuracy and precision empowers more personalized treatments for more patients.

Discover if the RO-APM will be available in your area with our interactive map

CMS has identified and published a list of over 9,000 zip codes to participate in the initial roll out. Search for your zip code below to find out if your area is included.

Hypofractionation is the Essential Radiation Oncology Modality for Value-Based Care

With the structure of the episodic payment model, as well as the specific language from CMS, the RO-APM aligns patient, provider and payer interests on a guiding maxim: treat with fewer fractions, whenever possible. This firmly establishes hypofractionation as an essential treatment modality for every radiation oncology practice.

Delivering Confidence in Hypofractionation

Accuray treatment delivery systems provide the critical capabilities that radiation oncology practices need in order to deliver hypofractionated radiotherapy cancer treatments with complete confidence in safety.  Unparalleled clinical efficiency of the latest CyberKnife® and Radixact® treatment delivery systems empower radiation oncology practices to achieve emerging clinical best practices, adapt to new economic realities and thrive in a value-based care landscape.

Radixact and CyberKnife radiation therapy systems

Accuray Delivers

CONFIDENCE IN SAFE HYPOFRACTIONATION

As the pioneer of stereotactic body radiotherapy (SBRT), Accuray technology was the first to make hypofractionation practical and precise for any radiation oncology practice. For the last two decades, Accuray has remained the leading innovator in hypofractionation, continually developing and honing technologies that push the practice of hypofractionated radiotherapy forward. Today, Accuray technologies are supported by a broad range of clinical evidence demonstrating their safety and efficacy in delivering hypofractionated treatments

CONFIDENCE IN CLINICAL EFFICIENCY

As the pioneer in hypofractionation, Accuray designed its treatment delivery systems from the ground up to deliver on the full benefits — clinical, economic and patient — of hypofractionated radiotherapy. Accuray Systems give clinicians industry-leading precision and accuracy without slowing clinical workflows and without burdening clinical efficiency.

Sub-Millimeter Precision & Accuracy

Accuray treatment delivery systems feature several industry-leading capabilities that give clinicians complete confidence that radiation treatment dose is delivered precisely and accurately as described in the treatment plan. A plan that can be constructed with steep dose gradients and the ability to minimize dose to healthy tissue for unwanted radiation.

PRECISION

PRECISION

The CyberKnife® S7™ System uses the world’s only radiotherapy robot — capable of delivering thousands of non isocentric, non-coplanar or coplanar beam angles — to deliver SRS and SBRT treatments precisely to any point on the body.

DOSE SCULPTING

The CyberKnife system features the industry’s only robotic-arm-mounted  multi-leaf collimator, the Incise™ MLC, capable of advanced beam-shaping that enhances delivery precision. This dose-sculpting ability enables clinicians to create treatment plans with significantly smaller margins and sharp dose gradients, supporting hypofractionated treatment.

MOTION SYNCHRONIZATION

Accuray pioneered the first-of-its-kind Synchrony® technology on the CyberKnife system more than 15 years ago. Synchrony leverages CyberKnife system’s unique robotic precision to enable automatic and real-time 6D motion synchronization.

PRECISION

PRECISION

The Radixact® System uses true, 360-degree helical imaging and  delivery to deliver dose from literally any angle, setting a new standard  for delivery precision anywhere in the body and enabling IG-IMRT, SRS, SBRT and 3DCRT for the full range of indications.

DOSE SCULPTING

The Radixact system features an ultra-fast multi-leaf collimator and TomoEDGE™ dynamic jaws for enhanced beam-shaping. Together with true helical delivery, these capabilities enable clinicians to confidently create plans with smaller margins and share dose gradients, supporting hypofractionated treatment.

MOTION SYNCHRONIZATION

The proven, industry-leading Synchrony technology is now available for the Radixact System. Synchrony leverages Radixact’s helical delivery and advanced beam-shaping capabilities to enable automatic and real-time  motion synchronization.

ACCURACY

The unparalleled combination of precise dose-sculpting and real-time motion synchronization offered by both the CyberKnife and Radixact Systems give clinicians confidence that small-margin, sharp-gradient treatment plans are delivered accurately to protect patient safety — empowering safe delivery of hypofractionated treatments while minimizing dose to healthy tissue.

Synchronizing with Intra-Fraction Target Motion — Without Interrupting Treatment Delivery

Accuray pioneered the industry’s first and only true motion-synchronization technology, giving radiation oncologists the ability to precisely synchronize treatment delivery with patient and tumor motion in real-time. Synchrony® — available for both the CyberKnife and Radixact Systems — combines fully integrated imaging and indication-specific tracking applications to enable constant intra-fraction position tracking and automatic motion synchronization of the treatment delivery beam to the moving target without involvement of the patient or intervention by the technologist. This gives radiation oncologists the confidence to deliver hypofractionated treatments while minimizing dose to healthy tissue and protecting patient safety. Unlike gating or patient repositioning, Accuray Synchrony technology enables radiation oncologists to synchronize treatment delivery with target motion during continuous, uninterrupted treatment delivery.

See How Synchrony Elminates Clinical Tradeoffs

Accuray PreciseART® Adaptive Radiotherapy Option

Automating Adaptive Radiotherapy — Making Adaptive RT Practical for Every Practice

Accuray treatment delivery systems provide the critical capabilities that radiation oncology practices need in order to deliver hypofractionated radiotherapy cancer treatments with complete confidence in safety.  Unparalleled clinical efficiency of the latest CyberKnife® and Radixact® treatment delivery systems empower radiation oncology practices to achieve emerging clinical best practices, adapt to new economic realities and thrive in a value-based care landscape.

Shared Goals: Clinical Outcomes, Patient Experience and Cost Control

At Accuray, we’ve been developing strategies for delivering value-based care with Accuray technologies for several years. We know the goal isn’t simply to drive down costs or protect margins. Every clinician we work with is focused on clinical outcomes and patient experience. Financial outcomes, while critical, always seem secondary. We believe it’s our obligation as a technology manufacturer to provide our customers with technologies that do both — allow them to continually improve the quality of care and protect their hard-earned margins.

TDABC: A Complex Acronym for a Simple (and Useful) Accounting Method

Time-Driven-Activity-Based-Costing (TDABC) is simply a cost accounting method designed to measure the time and cost of delivering various forms of care, including radiation therapy. It’s designed to give providers insight and control as the U.S. healthcare market migrates to value-based care. These insights are important, because, in general, the cost of providing medical treatments has historically been neither transparent nor well understood. Deployed properly, TDABC enables analytics around productivity, effectiveness, cost and margins for the procedures and processes surrounding specific medical interventions.

TDABC Insights from Accuray

Knowledge is power, especially when trying to understand the financial implications of new treatment workflows. Accuray has worked with several providers to deploy TDABC models in their radiation oncology practices. Benefits of TDABC include:

Unmatched service to protect uptime and maximize ROI

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

Redefining the future of cancer care

Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.

Accuray treatment options

The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.

Treatment Centers

About Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.